HOXB7 Modified Stem Cells for Extended Regenerative Capacity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The regenerative potential of stem cells is temporary due to age-related decline in proliferative and differentiative capacity, and existing methods for enhancing stem cell function are limited by the short-lasting therapeutic effects and potential risks of immortalization.
Innovation Solution
Genetic modification of cells to overexpress the HOXB7 protein, which increases proliferative capacity, reduces senescence, and enhances differentiative potential, allowing for optimized ex vivo expansion and extended therapeutic effectiveness, while also facilitating bone tissue regeneration through increased production of growth factors like bFGF.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of moving object
If stem cells are used for regenerative medicine applications, then their proliferative and differentiative potential can be utilized, but their regenerative potential is temporary due to age-related decline in cell function
Solution Approach 1:
The patent introduces HOX genes (specifically HOXB4, HOXA9, HOXA10) to alter the biological parameters of stem cells, transforming their aging trajectory. These genes modify cellular behavior to maintain youthful characteristics, effectively changing the temporal parameters of cell function and extending therapeutic durability beyond natural limitations
Solution Approach 2:
HOX genes serve as molecular intermediaries that mediate between the stem cell's intrinsic aging processes and the desired extended functional state. By introducing these transcription factors, the patent creates a bridging mechanism that counteracts age-related decline and maintains cellular potency over time
2Duration of action of moving object
If HOX genes are introduced to extend stem cell function, then proliferative capacity and therapeutic duration are improved, but genetic modification carries potential risks
Solution Approach 1:
The patent employs viral vectors (lentivirus, retrovirus) as transient delivery vehicles for HOX genes. These vectors serve their purpose of gene delivery and then can be cleared from the system, avoiding permanent integration risks while achieving the desired extended therapeutic effect through controlled, temporary genetic modification
Solution Approach 2:
The patent incorporates regulatory elements that allow feedback control of HOX gene expression. This includes using endogenous promoters and regulatory sequences that respond to cellular conditions, ensuring that gene expression remains within safe boundaries and automatically adjusts to prevent overexpression-related hazards
3Productivity
If stem cells are expanded ex vivo, then more cells are available for therapy, but age-related decline reduces proliferative capacity over time
Solution Approach 1:
The patent applies HOX gene modification before the stem cells undergo extensive ex vivo expansion. This preliminary genetic intervention primes the cells to maintain their proliferative capacity throughout the expansion process, preventing age-related decline from setting in during culture and ensuring robust cell growth for therapeutic dosing
Data Source
AI summary
A cell modified for obtaining increased proliferative capacity, decreased aging and enhanced regenerative capacity, its modification involving HOXB7 overexpression obtained using a gene vector that can insert the coding sequence into the cell, thereby affording increased protein production.